Aurora Cannabis Repurchases $76.1M Principal Amount Of Convertible Notes

Aurora Cannabis Inc. ACB ACB has repurchased an aggregate of approximately CA$102.5 million ($76.1 million) principal amount of its convertible senior notes at a total cost, including accrued interest, of CA$99.4 million ($73.8 million) in cash. Following completion of this repurchase, Aurora will have approximately CA$148 million ($110 million) of notes outstanding.

The purpose of the transaction, which represents a repurchase of a portion of the notes at a 4.5% discount to par value, was to reduce the company's debt and annual cash interest costs. Aurora has repurchased an aggregate of approximately CA$316.5 million ($235 million) principal amount of its convertible senior notes over the last twelve months, resulting in annual cash interest savings of approximately CA$17.4 million ($12.9 million).

The company reiterated its expectation of achieving adjusted EBITDA profitability by December 31, 2022.

Get your daily dose of cannabis news on Benzinga Cannabis. Don’t miss out on any important developments in the industry.

Photo by Giorgio Trovato on Unsplash

Related News

Curaleaf Lays Off 220 Employees To Control Costs, Drive Efficiencies: Trend As Cannabis Companies Struggle?

Aurora Cannabis: What Makes Upside Potential For This Pot Stock? Analyst Has An Idea

Spain Seizes World's Largest Cannabis Haul To Date, Group Busted Was Supplying Most Of Europe

 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsPenny StocksSmall CapMarketspremium
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.